IRIS Research and Development, LLC
2 clinical trials · Sponsor
◉ Watch IRIS Research and Development, LLC
| Record | Firm | Date |
|---|---|---|
| Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. (NCT06581562) | IRIS Research and Development, LLC | 2024-05-15 |
| Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS) (NCT03419650) | IRIS Research and Development, LLC | 2018-07-20 |
Track IRIS Research and Development, LLC automatically
Every clearance here is in the API, with alerts when new ones post.